Atlas Trials

Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

Clinical trial NCT05897879 · RECRUITING

Trial details

NCT number
NCT05897879
Sponsor
Institut Pasteur
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Bordetella Pertussis, Whooping Cough
Start date
2023-11-16
Primary completion
2025-11-16
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.